Kazia Therapeutics Ltd - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Kazia Therapeutics Ltd - ADR
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Kazia Therapeutics Ltd - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Kazia Therapeutics Ltd - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Kazia Therapeutics Ltd - ADR is KZIA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Kazia Therapeutics Ltd - ADR has its primary listing on NASDAQ. You can trade Kazia Therapeutics Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Kazia Therapeutics Ltd - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Kazia Therapeutics Ltd - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Kazia Therapeutics Ltd - ADR.